Selected article for: "disease progression and negative effect"
Author: Ting Ding; Jinjin Zhang; Tian Wang; Pengfei Cui; Zhe Chen; Jingjing Jiang; Su Zhou; Jun Dai; Bo Wang; Suzhen Yuan; Wenqing Ma; Lingwei Ma; Yueguang Rong; Jiang Chang; Xiaoping Miao; Xiangyi Ma; Shixuan Wang
Title: A Multi-hospital Study in Wuhan, China:Protective Effects of Non-menopause and Female Hormones on SARS-CoV-2 infection
  • Document date: 2020_3_30
    • ID: lplodn60_46
    Snippet: AMH levels were positively associated with the number of oocytes retrieved, ovarian response, E2 and testosterone 16 . Logistics regression analyses showed that the levels of E2 and AMH in non-severe group are higher than that of the severe group, which may play vital roles in the progression of COVID-19. In this study, non-severe females have higher levels of testosterone than do severe patients. Previous studies have shown that testosterone has.....
    Document: AMH levels were positively associated with the number of oocytes retrieved, ovarian response, E2 and testosterone 16 . Logistics regression analyses showed that the levels of E2 and AMH in non-severe group are higher than that of the severe group, which may play vital roles in the progression of COVID-19. In this study, non-severe females have higher levels of testosterone than do severe patients. Previous studies have shown that testosterone has suppressive effects on immune system, such as on cytokine production and lymphocyte proliferation 17 . However, after adjusted by age, the significance became unobvious. In the disease progression of COVID-19, testosterone may work by suppressing immune storms. Our results also indicated that E2 has a stronger protective effect against the potential negative effects from testosterone.

    Search related documents:
    Co phrase search for related documents
    • age adjust and logistic regression analysis: 1
    • age adjust and non severe group: 1
    • age adjust and severe group: 1, 2
    • AMH level and logistic regression: 1
    • AMH level and previous study: 1
    • AMH level and severe group: 1
    • cytokine production and disease progression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cytokine production and high level: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • cytokine production and immune storm: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
    • cytokine production and immune system: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74
    • cytokine production and logistic regression: 1, 2, 3, 4, 5
    • cytokine production and logistic regression analysis: 1, 2
    • cytokine production and lymphocyte cytokine production: 1, 2, 3, 4, 5, 6
    • cytokine production and previous study: 1, 2, 3, 4
    • cytokine production and protective effect: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • cytokine production and severe group: 1, 2, 3, 4, 5
    • cytokine production and severe patient: 1, 2
    • cytokine production and suppressive effect: 1, 2
    • cytokine production and vital role: 1, 2